Diagnostic options · UAE

Genetics tests in Dubai & UAE

Compare available Genetics tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

2,789

Listed price range

-1.00–50,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Genetics test prices

Showing 136–150 of 2,789 matching tests.

Genetics diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-1852 AML Cytogenetics & FISH Panel Test This test evaluates chromosomal abnormalities and gene rearrangements associated with acute myeloid leukemia (AML). It combines karyotyping and Fluorescence In Situ Hybridization (...	Bone marrow aspirate or peripheral blood	10 days (FISH results available within 3–5 days for critical markers)	2,400.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Chromosomal rearrangements (karyotyping)", "Specific gene rearrangements (FISH: AML/ETO, inv(16), PML/RARA, MLL)"] Parameters [] Preparation ["No special preparation required", "Doctor’s prescription and clinical history form are mandatory"] Indications ["Diagnosis of acute myeloid leukemia (AML)", "Risk stratification in AML", "Guiding targeted therapy selection in AML"] Measurement technique Confirm with laboratory Codes LOINC: 79521-9 ICD-10: C92.00, C92.01, C92.02 Clinical summary This test evaluates chromosomal abnormalities and gene rearrangements associated with acute myeloid leukemia (AML). It combines karyotyping and Fluorescence In Situ Hybridization (FISH) to identify specific genetic markers.
TEST-1858 AML FISH Panel Test This diagnostic test evaluates for the presence of four specific chromosomal rearrangements commonly found in Acute Myeloid Leukemia (AML) using Fluorescence In-Situ Hybridization...	Bone Marrow Aspirate or Peripheral Blood	10 Business Days	2,000.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["t(8;21)(q22;q22) / AML1-ETO rearrangement", "inv(16)(p13.1q22) / CBFB-MYH11 rearrangement", "t(15;17)(q24.1;q21.2) / PML-RARA rearrangement", "Rearrangements involving 11q23 / MLL (KMT2A)"] Parameters [{"name": "Diagnostic Sensitivity", "reference_range": "99.9%"}] Preparation ["No fasting required", "Inform doctor about anticoagulant medications", "Valid physician prescription required"] Indications ["Diagnosis of Acute Myeloid Leukemia (AML)", "Risk stratification in AML", "Guidance for targeted therapy selection in AML"] Measurement technique Confirm with laboratory Codes LOINC: 96589-0 ICD-10: C92.00, C92.50, Z15.01 Clinical summary This diagnostic test evaluates for the presence of four specific chromosomal rearrangements commonly found in Acute Myeloid Leukemia (AML) using Fluorescence In-Situ Hybridization (FISH). It provides rapid genetic information essential for AML classification and treatment planning.
TEST-5978 AMPD1 Gene Myopathy Due to Myoadenylate Deaminase Deficiency Test This test identifies pathogenic variants in the AMPD1 gene, confirming myoadenylate deaminase deficiency.	Whole Blood, Extracted DNA, or One Drop on FTA Card	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the AMPD1 gene", "Myoadenylate deaminase enzyme deficiency"] Parameters [{"name": "AMPD1 Gene Sequencing", "reference_range": "No pathogenic variants detected"}] Preparation ["Genetic counselling session & pedigree charting required", "No fasting or special diet required"] Indications ["Patients with symptoms suggestive of MADD", "Differential diagnosis of exertional muscle disorders"] Measurement technique Confirm with laboratory Codes LOINC: 81247-9 ICD-10: E79.8 Clinical summary This test identifies pathogenic variants in the AMPD1 gene, confirming myoadenylate deaminase deficiency.
TEST-3836 AMT Gene Glycine Encephalopathy Genetic Test This test evaluates the AMT gene for pathogenic variants associated with glycine encephalopathy (nonketotic hyperglycinemia). It utilizes Next-Generation Sequencing (NGS) for compr...	Peripheral Whole Blood, Blood Spot on FTA Card, or Extracted DNA	21–28 Business Days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the AMT gene", "Coding region and flanking exon-intron boundaries of the AMT gene"] Parameters [] Preparation ["No specific fasting required", "Inform lab if patient is on anticoagulant therapy"] Indications ["Suspected diagnosis of glycine encephalopathy (nonketotic hyperglycinemia)", "Family history of glycine encephalopathy", "Carrier screening for at-risk individuals", "Prenatal diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 94222-5 ICD-10: E72.51 Clinical summary This test evaluates the AMT gene for pathogenic variants associated with glycine encephalopathy (nonketotic hyperglycinemia). It utilizes Next-Generation Sequencing (NGS) for comprehensive analysis.
TEST-5388 AMTN Gene Amelotin Deficiency Genetic Test This genetic test identifies pathogenic variants in the AMTN gene associated with amelogenesis imperfecta and related syndromes.	Whole Blood (EDTA/FTA Card) or Extracted DNA	3-4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["AMTN gene pathogenic variants", "Copy Number Variations (CNVs)"] Parameters [] Preparation ["No specific fasting required", "Inform phlebotomist of any medications"] Indications ["Diagnosis of amelogenesis imperfecta", "Identification of genetic predisposition to related syndromes", "Genetic counseling for affected families"] Measurement technique Confirm with laboratory Codes LOINC: 82301-8 ICD-10: K00.5 Clinical summary This genetic test identifies pathogenic variants in the AMTN gene associated with amelogenesis imperfecta and related syndromes.
TEST-3666 Amyotrophic Lateral Sclerosis (ALS) Panel Genetic Test This genetic test identifies pathogenic variants in multiple genes associated with Amyotrophic Lateral Sclerosis (ALS). It helps confirm a genetic diagnosis and provides informatio...	Peripheral whole blood (3-5 mL in EDTA tube) or dried blood spot (FTA card)	3-4 Weeks	3,000.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in ALS-associated genes (e.g., SOD1, C9orf72, TARDBP, FUS)", "Genetic predisposition to ALS"] Parameters [] Preparation [] Indications ["Suspected diagnosis of ALS", "Family history of ALS", "Differential diagnosis of motor neuron disease"] Measurement technique Confirm with laboratory Codes LOINC: 101234-0 ICD-10: G12.21 Clinical summary This genetic test identifies pathogenic variants in multiple genes associated with Amyotrophic Lateral Sclerosis (ALS). It helps confirm a genetic diagnosis and provides information for prognosis and genetic counseling.
TEST-259 Angelman Syndrome Genetic Test This test evaluates DNA methylation patterns at the 15q11-q13 locus to diagnose Angelman syndrome.	EDTA whole blood	12 Working Days	1,500.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["DNA methylation patterns", "15q11-q13 imprinting center defects", "Maternal deletion of chromosome 15q11-q13", "Paternal uniparental disomy"] Parameters [] Preparation ["No fasting required", "Maintain current medication regimen unless advised otherwise by a physician"] Indications ["Clinical suspicion of Angelman syndrome based on characteristic features", "Developmental delay or intellectual disability of unknown cause", "Family history of Angelman syndrome"] Measurement technique Confirm with laboratory Codes LOINC: 21774-8 ICD-10: Q93.51 Clinical summary This test evaluates DNA methylation patterns at the 15q11-q13 locus to diagnose Angelman syndrome.
TEST-4973 ANK3 Gene Mental Retardation, Autosomal Recessive Type 37 (MRT37) Genetic Test This genetic test identifies pathogenic variants within the ANK3 gene associated with autosomal recessive intellectual disability type 37 (MRT37).	Whole Blood (3-5 mL EDTA), Extracted DNA, or FTA Card	3–4 weeks from sample receipt	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["ANK3 gene sequence", "Pathogenic variants in ANK3"] Parameters [] Preparation ["Pre-test genetic counseling session required", "Obtain informed consent"] Indications ["Confirmation of clinical diagnosis for MRT37", "Genetic counseling for intellectual disability", "Family planning in cases of suspected recessive inheritance"] Measurement technique Confirm with laboratory Codes LOINC: 93928-2 ICD-10: F78.8 Clinical summary This genetic test identifies pathogenic variants within the ANK3 gene associated with autosomal recessive intellectual disability type 37 (MRT37).
TEST-5291 ANKH Gene Chondrocalcinosis Type 2 Genetic Test This test evaluates the ANKH gene for pathogenic variants associated with familial calcium pyrophosphate deposition disease (CPPD), also known as chondrocalcinosis type 2.	Whole Blood, Extracted DNA, or FTA Card Blood Spot	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the ANKH gene", "Single-nucleotide variants", "Insertions", "Deletions", "Copy-number changes"] Parameters [] Preparation ["Complete a genetic counselling session", "Provide a detailed three-generation family pedigree chart", "No fasting required", "Inform phlebotomist of any blood-thinning medications"] Indications ["Suspicion of familial calcium pyrophosphate deposition disease (CPPD)", "Family history of chondrocalcinosis", "Need for definitive molecular diagnosis to guide management and family screening"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: M11.2 Clinical summary This test evaluates the ANKH gene for pathogenic variants associated with familial calcium pyrophosphate deposition disease (CPPD), also known as chondrocalcinosis type 2.
TEST-2919 ANKH Gene Craniometaphyseal Dysplasia Genetic Test This test identifies pathogenic variants in the ANKH gene associated with Craniometaphyseal Dysplasia (CMD).	Whole Blood (EDTA), Extracted DNA, or Dried Blood Spot (FTA Card)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the ANKH gene"] Parameters [] Preparation ["Provide comprehensive clinical history", "Genetic counselling session required for pedigree chart"] Indications ["Suspected Craniometaphyseal Dysplasia (CMD)", "Family history of CMD", "Genetic counselling for at-risk individuals"] Measurement technique Confirm with laboratory Codes LOINC: 82810-7 ICD-10: Q78.8, Q75.8, Z13.79 Clinical summary This test identifies pathogenic variants in the ANKH gene associated with Craniometaphyseal Dysplasia (CMD).
TEST-2686 ANKRD11 Gene Genetic Test for KBG Syndrome This test evaluates the ANKRD11 gene for pathogenic variants associated with KBG syndrome.	Peripheral whole blood (EDTA)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the ANKRD11 gene", "Single nucleotide variants (SNVs)", "Insertions/deletions (indels)", "Small copy number variations (CNVs)"] Parameters [] Preparation [] Indications ["Clinical suspicion of KBG syndrome", "Confirmation of diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 81263-6 ICD-10: Q87.89 Clinical summary This test evaluates the ANKRD11 gene for pathogenic variants associated with KBG syndrome.
TEST-3877 ANKS3 Gene Autism Spectrum Disorder Genetic Test This test evaluates the ANKS3 gene for variants associated with Autism Spectrum Disorder (ASD).	Whole Blood (Peripheral Venipuncture)	3–4 Weeks (21–28 Business Days)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Single nucleotide variants in ANKS3 gene", "Small insertions or deletions (indels) in ANKS3 gene", "Copy Number Variations (CNV) in ANKS3 gene"] Parameters [] Preparation ["No specific fasting required", "Inform phlebotomist of any anticoagulant therapy"] Indications ["Clinical suspicion of Autism Spectrum Disorder (ASD)", "Familial risk stratification for ASD", "Personalized intervention planning for ASD"] Measurement technique Confirm with laboratory Codes LOINC: 91854-2 ICD-10: F84.0 Clinical summary This test evaluates the ANKS3 gene for variants associated with Autism Spectrum Disorder (ASD).
TEST-5848 ANO10 Gene Spinocerebellar Ataxia Type 10, Autosomal Recessive Genetic Test This test evaluates the ANO10 gene for pathogenic variants associated with autosomal recessive spinocerebellar ataxia type 10 (SCAR10). It identifies mutations responsible for the...	Whole Blood, Extracted DNA, or One Drop of Blood on an FTA Card	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the ANO10 gene", "Single nucleotide variants (SNVs)", "Small insertions and deletions (indels)"] Parameters [] Preparation ["No specific fasting required", "No medication adjustments needed before the test"] Indications ["Individuals with clinical features suggestive of spinocerebellar ataxia type 10", "Family history of SCAR10", "Carrier screening in families with known SCAR10 mutations"] Measurement technique Confirm with laboratory Codes LOINC: 21657-1 ICD-10: G11.2 Clinical summary This test evaluates the ANO10 gene for pathogenic variants associated with autosomal recessive spinocerebellar ataxia type 10 (SCAR10). It identifies mutations responsible for the neurological disorder.
TEST-4204 ANO3 Gene (DYT24) Genetic Test This test evaluates the ANO3 gene for pathogenic variants associated with autosomal dominant dystonia type 24.	Whole blood (2–5 mL EDTA), extracted DNA (≥1 µg), or FTA card (3 dried blood spots)	3–4 weeks (expedited 2-week option available)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["ANO3 gene coding region", "ANO3 gene splice sites", "Pathogenic variants"] Parameters [] Preparation [] Indications ["Individuals with early-onset cervical or laryngeal dystonia", "Individuals with a family history of dystonia", "Individuals with unexplained movement disorders"] Measurement technique Confirm with laboratory Codes LOINC: 102022-8 ICD-10: G24.1 Clinical summary This test evaluates the ANO3 gene for pathogenic variants associated with autosomal dominant dystonia type 24.
TEST-5058 ANO5 Gene Gnathodiaphyseal Dysplasia Genetic Test This test analyzes the ANO5 gene for mutations associated with gnathodiaphyseal dysplasia (GDD). It identifies variants like single-nucleotide changes, insertions/deletions, and co...	Peripheral whole blood	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["ANO5 gene variants", "Single-nucleotide variants", "Insertions/deletions", "Copy-number variations"] Parameters [] Preparation ["Detailed clinical history focusing on jaw, dental, or long-bone symptoms is required.", "Mandatory genetic counselling session to construct a pedigree chart.", "No dietary or drug restrictions are necessary; continue all prescribed medications unless advised otherwise."] Indications ["Individuals with compatible clinical features", "Family history of GDD", "Inconclusive radiographic findings"] Measurement technique Confirm with laboratory Codes LOINC: 82293-6 ICD-10: M85.8, Z13.89 Clinical summary This test analyzes the ANO5 gene for mutations associated with gnathodiaphyseal dysplasia (GDD). It identifies variants like single-nucleotide changes, insertions/deletions, and copy-number variations.

Category overview

Genetics: overview

Understanding your unique biological blueprint offers a profound sense of clarity and empowers proactive health planning for you and your family. At DNA Labs UAE, our specialized Genetics division employs state-of-the-art molecular technologies to provide deep insights into hereditary markers and cellular mutations. This comprehensive genetics testing in the UAE equips your healthcare provider with the precise data needed to tailor your medical guidance effectively. Recognized among top diagnostic labs in Dubai and the UAE, we prioritize your peace of mind through strict confidentiality protocols and exceptionally fast, accurate reporting. Take the next step in your health journey. View our genetics diagnostic services, book a private home collection, or consult our specialized team today.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.

Explore this area

Genetics tests in Dubai & UAE

Genetics test prices

Genetics: overview

Use the test details as a conversation starter

Related Genetics categories